Top 50 Ai Diagnostics in Asia

Zhijian Life develops AI-driven diagnostic solutions that integrate pathological medical big data with advanced imaging and analysis techniques. Their technology enhances the accuracy and efficiency of disease diagnosis, particularly in oncology and chronic kidney disease, by providing automated insights from digital pathology images.

IBEX develops AI-powered diagnostic solutions that enhance the accuracy and efficiency of cancer detection by analyzing tissue samples with deep learning algorithms trained on over 10 million pathology slides. This technology provides pathologists with reliable insights, improving diagnostic confidence and patient outcomes in cancer care.

Dectrocel HealthCare and Research provides an automated AI-based diagnostic platform that processes digital imaging data to deliver instant, personalized diagnostic reports for conditions such as cancer and tuberculosis. This solution eliminates the need for costly imaging films and enables rapid diagnosis in various healthcare settings, including rural clinics, enhancing the efficiency of patient care.

MEDHINI is a generative AI-powered software platform that provides genomics-based multimodal solutions for healthcare diagnostics, focusing on areas such as antimicrobial resistance and virtual clinical trials. The platform enhances diagnostic accuracy and accessibility in pulmonology, neurology, nephrology, cardiology, and oncology, addressing the need for affordable healthcare solutions with measurable social impact.

The startup operates an AI-based diagnostic platform that enables rapid blood analysis directly at peripheral clinics, eliminating the need for extensive maintenance and operational costs. This technology enhances diagnostic accuracy and significantly reduces the time required for obtaining test results, improving patient care in underserved areas.

Predoc provides an AI-powered platform that aggregates and standardizes disparate patient health records from numerous sources across the US. This service transforms unstructured data like faxes and PDFs into FHIR-ready, structured clinical summaries delivered via API. The platform aims to eliminate administrative burdens for healthcare organizations by accelerating access to complete patient data for improved care delivery and operational efficiency.

VinBrain provides artificial intelligence solutions for medical image diagnostics, utilizing deep learning algorithms to enhance the accuracy of radiological assessments. By automating image analysis, VinBrain reduces the time required for diagnosis and improves clinical decision-making in healthcare settings.

The startup specializes in digital diagnostics for infectious and chronic diseases using advanced biomarker analysis and machine learning algorithms. This technology enhances disease detection accuracy and accelerates patient management, addressing the need for timely and precise medical insights.

Quanzhentong develops medical AI products that enhance diagnostic accuracy and operational efficiency in hospitals through advanced data analytics and machine learning algorithms. The platform addresses the challenges of patient management and treatment optimization by providing actionable insights from clinical data.

Develops an AI-powered digital pathology platform that integrates with major laboratory information systems (LIS) and electronic medical records (EMR) to automate and standardize cancer diagnosis. By analyzing whole-slide images in seconds and providing a vendor-agnostic workflow, it improves diagnostic accuracy, reduces costs, and enables remote pathology, allowing pathologists to focus on complex cases.

Lingxin Intelligence is an interactive AI platform that utilizes machine learning algorithms for digital diagnosis in healthcare. The platform enhances diagnostic accuracy and efficiency, enabling healthcare professionals to make informed decisions based on real-time data analysis.

N.Cer develops AI-driven medical devices that employ machine learning algorithms to improve diagnostic accuracy and treatment effectiveness in healthcare. The technology provides precise, data-driven insights that enhance clinical decision-making, ultimately leading to better patient outcomes.

Uses machine learning algorithms to analyze patient data and improve diagnostic accuracy, streamline healthcare operations, and enhance treatment outcomes. By integrating AI-driven solutions into clinical workflows, it addresses inefficiencies and variability in patient care, enabling healthcare providers to deliver more precise and timely interventions.

Endimension develops AI-driven tools for medical image analysis that enhance diagnostic accuracy and streamline radiology reporting workflows. By automating the identification and quantification of abnormalities, their solutions improve efficiency and reduce the risk of diagnostic errors in imaging centers.

AI Medical Service develops AI-powered diagnostic software for endoscopic imaging to enhance the detection of gastric and colorectal cancers. Their technology addresses the issue of missed early-stage cancers during endoscopic examinations, which can lead to higher mortality rates.

5C Network provides teleradiology services utilizing AI-driven analysis for MRI, CT, PETCT, and X-ray scans, enabling autonomous detection of pathologies and generating preliminary reports for urgent cases. This technology enhances diagnostic accuracy and reduces turnaround times, improving workflow efficiency for radiologists and healthcare providers.

This healthcare technology company develops AI-powered diagnostic tools for early and precise detection of various disorders. Their platform provides accessible diagnostic insights, enabling healthcare providers to make timely interventions and improve patient outcomes.

Livo develops automated pathology equipment for point-of-care blood analysis and whole slide imaging, utilizing AI to enhance blood cell morphology analysis and expedite diagnostic processes. Their technology addresses the need for faster and more accurate diagnostics in healthcare, providing results in as little as 60 seconds while ensuring affordability and accessibility.

Vetotec provides AI-driven remote diagnostic imaging services for veterinary health checkups, enhancing the accuracy and efficiency of animal diagnostics. By leveraging advanced imaging technology, Vetotec enables veterinarians to deliver timely and precise care, improving health outcomes for pets and peace of mind for their owners.

1Cell provides an AI-powered single‑cell liquid biopsy platform that isolates circulating tumor cells and generates multi‑omics profiles in real time. The system combines high‑throughput cell capture hardware with machine‑learning analytics to deliver molecular signatures for early cancer detection, therapy response prediction, and disease monitoring.

This startup develops AI-powered medical diagnosis software for infants and musculoskeletal patients. Their platform analyzes medical data to improve diagnostic accuracy and facilitate rapid, customized treatment plans for foot diseases and musculoskeletal conditions.

This company develops an AIoT-based smart healthcare platform offering real-time health monitoring and personalized medical recommendations. The platform integrates multi-modal data from devices and AI diagnostic systems to provide comprehensive health management. They offer services through device sales, subscription models, and API licensing to healthcare providers and insurance partners.

IR-Med develops a spectrographic AI-based technology platform for non-invasive biomarker analysis at the point of care. This handheld technology provides real-time assessment of blood and tissue to support clinical decision-making. Applications include early detection of pressure injuries, diabetic foot ulcers, and non-invasive drug level monitoring.

Yizhun Intelligent develops artificial intelligence solutions specifically for the medical industry, focusing on enhancing diagnostic accuracy and operational efficiency. The technology addresses the challenges of data management and analysis in healthcare, enabling faster and more reliable patient care decisions.

Reetoo Biotech integrates artificial intelligence with medical diagnostic processes to enhance the accuracy and speed of disease detection. The company addresses the challenge of misdiagnosis and delayed treatment by providing data-driven insights that improve clinical decision-making.

Predictoma provides an AI-powered prognostic test for ductal carcinoma in situ (DCIS) to assess breast cancer recurrence risk. This machine learning platform analyzes tissue samples to offer physicians more accurate information for treatment guidance. The HIPAA-compliant service is grounded in peer-reviewed research and aims to reduce unnecessary surgery for low-risk patients.

Pasbox utilizes artificial intelligence to analyze molecular biology data, providing healthcare solutions that enhance patient outcomes. The platform addresses inefficiencies in data interpretation and decision-making in clinical settings, enabling faster and more accurate diagnostics.

Curve Biosciences develops Whole-Body Intelligence models using a proprietary Whole-Body Atlas of over 400,000 curated tissue samples. These models power Whole-Body Blood Tests designed to monitor organ health in chronic disease patients. This approach aims to provide more accurate monitoring than standard methods for managing long-term health conditions.

Way2Deep develops AI-driven algorithms for medical imaging and signal processing, focusing on enhancing the accuracy of MRI, CT, and ultrasound diagnostics. The company addresses the need for precise image acquisition and analysis in healthcare, defense, and various industries, ensuring compliance with regulatory standards.

The startup develops an AI-based decision support system specifically for the radiology industry, offering teleradiology services and radiology optimization platforms. This technology enables radiologists to manage their workload more efficiently and accelerate the diagnostic process.

Shizhijue develops AI-powered ultrasound technology that accurately identifies and analyzes neural, muscular, and tendon tissues from complex ultrasound images. The platform enhances clinical diagnostics by providing precise comparisons of healthy and affected tissues, improving the speed and accuracy of disease localization.

Intellindust develops optical imaging and visual AI technologies to enhance image analysis and interpretation in various applications. Their solutions improve accuracy and efficiency in fields such as medical diagnostics and industrial inspection, addressing the need for reliable visual data processing.

Medical Image Insights integrates artificial intelligence into medical imaging to enhance diagnostic accuracy and efficiency for radiologists. The platform provides tailored AI tools and a self-service research environment, addressing the need for advanced analytics in medical imaging workflows.

Plasmon.ai utilizes spectroscopy to enhance healthcare analytics, providing precise and rapid insights for medical decision-making. This technology addresses the challenge of slow and inaccurate data analysis in healthcare, enabling clinicians to make informed decisions more efficiently.

Aipore develops nanopore sensors utilizing semiconductor silicon microfabrication technology to achieve high measurement stability and precision. Their AI-driven analysis enables the identification of viral and bacterial subtypes at the single-particle level, facilitating rapid and accurate diagnostics for emerging pathogens.

Biova Health provides a handheld, AI‑powered device that images kidney stone samples and identifies their composition within two minutes, delivering results directly to clinicians. The system stores analyses in a secure cloud and integrates with electronic health records, eliminating the need for external lab processing and reducing diagnostic time and cost for urology and nephrology practices.

AIMIRA Innovation Technology utilizes artificial intelligence to enhance diagnostic accuracy and optimize treatment plans in plastic surgery and anti-aging medicine. The company addresses the need for precise, data-driven medical solutions that improve patient outcomes and streamline clinical workflows.

Aillis develops and provides digital solutions focused on enhancing the quality of life for the elderly and supporting healthcare professionals. The company specializes in creating platforms that facilitate remote monitoring and personalized care management for aging populations. Their technology aims to improve efficiency in long-term care settings while ensuring better health outcomes for users.

W.AI has developed the world's first AI-powered diagnostic tool for breast implants, utilizing ultrasound and mammography images to accurately identify implant types and complications such as ruptures and capsular contracture. This technology addresses the challenge of diagnosing breast implant-related issues, which can often be misidentified due to overlapping symptoms.

The startup develops an artificial intelligence model that utilizes big data analytics for the early detection and prevention of cardiovascular disease. Its software provides health institutions with evidence-based clinical services to enhance diagnostic accuracy and improve patient outcomes globally.

Cybernetics Imaging Systems develops digital pathology scanners that utilize advanced optical technology and artificial intelligence to enhance diagnostic accuracy. Their solutions address the need for precise and efficient analysis of medical data, improving the speed and reliability of pathology workflows.

Pinnacles Medical utilizes artificial intelligence to assess healthcare needs and integrate diagnostic processes, providing tailored solutions for patient care. The company focuses on enhancing diagnostic accuracy and efficiency, addressing gaps in traditional healthcare evaluation methods.

Amplifai Health provides AI-powered thermal imaging for fast and objective diabetic foot screening at the point of care. The platform uses automated scan analysis to deliver real-time risk scores aligned with clinical guidelines. This supports care teams with proactive clinical decision support to intervene early and prevent complications.

The startup offers an AI-powered platform that diagnoses performance inconsistencies in process manufacturing and provides real-time insights and predictive diagnostics. This technology enables operators to enhance throughput, minimize energy consumption, and improve product quality while reducing operational costs.

The startup develops AI medical diagnosis software that utilizes endoscopic data to detect cancer and precancerous conditions in real-time. This technology enables proactive disease management by identifying risks early, allowing patients to engage in preventive care before cancer develops.

Prevenotics provides an AI-powered diagnostic solution that analyzes endoscopic images in real-time during gastroscopy. Its technology identifies pre-cancerous risks to improve early cancer detection and support prognosis management for stomach cancer prevention.

MetaDx develops AI-based solutions for veterinary diagnostics, focusing on early detection of companion animal tumors. The company provides cost-effective and reliable technology designed to standardize veterinary diagnostic capabilities. Their goal is to create technology that satisfies both veterinarians and pet owners.

NIRAMAI has developed Thermalytix, an AI-based breast cancer screening solution that utilizes thermal imaging technology to detect breast abnormalities without radiation or physical contact. This portable and automated system provides high accuracy in early-stage cancer detection, addressing the critical need for accessible and non-invasive screening methods for women of all ages.

Hevi AI develops deep learning software that enhances the accuracy and speed of radiological interpretations, specifically for stroke diagnosis. By analyzing over one million exams, their technology significantly reduces diagnostic time and improves patient outcomes in emergency care settings.

The startup develops deep learning algorithms that analyze electrocardiogram signals to detect silent cardiac conditions, such as diastolic dysfunction and low ejection fraction, enabling early diagnosis and preventive therapy. By utilizing a foundational model that requires significantly less data for training, the technology enhances diagnostic accuracy and streamlines clinical workflows, addressing the limitations of conventional cardiac diagnostics.